Valgene Incorporated, doing business as Cape Drugs, is recalling 39 vials of sterile injectable medications including Methylcobalamin (12mg/ml) and B-Complex. The recall affects 27 vials of Methylcobalamin and 12 vials of B-Complex that were distributed only in Maryland. The medications are being recalled because of a lack of processing controls, which could compromise the quality and sterility of the drugs. No injuries or illnesses have been reported to date.
The lack of processing controls for these sterile injectable drugs means the medications could be contaminated or fail to meet quality standards. Using improperly processed sterile injections could lead to serious health complications or infections.
Quantity: 27 vials
Quantity: 12 vials
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.